SMCO4
gene geneOn this page
Also known as FN5
Summary
SMCO4 (single-pass membrane protein with coiled-coil domains 4, HGNC:24810) is a protein-coding gene on chromosome 11q21, encoding Single-pass membrane and coiled-coil domain-containing protein 4 (Q9NRQ5).
Predicted to be located in membrane.
Source: NCBI Gene 56935 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_020179
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24810 |
| Approved symbol | SMCO4 |
| Name | single-pass membrane protein with coiled-coil domains 4 |
| Location | 11q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FN5 |
| Ensembl gene | ENSG00000166002 |
| Ensembl biotype | protein_coding |
| OMIM | 609477 |
| Entrez | 56935 |
Gene structure
Transcript identifiers
Ensembl transcripts: 46 — 46 protein_coding
ENST00000298966, ENST00000525141, ENST00000526869, ENST00000527149, ENST00000529714, ENST00000888171, ENST00000888172, ENST00000888173, ENST00000888174, ENST00000888175, ENST00000888176, ENST00000888177, ENST00000888178, ENST00000888179, ENST00000888180, ENST00000888181, ENST00000888182, ENST00000888183, ENST00000888184, ENST00000888185, ENST00000888186, ENST00000888187, ENST00000888188, ENST00000888189, ENST00000888190, ENST00000888191, ENST00000888192, ENST00000888193, ENST00000888194, ENST00000888195, ENST00000888196, ENST00000888197, ENST00000888198, ENST00000888199, ENST00000934129, ENST00000934130, ENST00000934131, ENST00000947544, ENST00000947545, ENST00000947546, ENST00000947547, ENST00000947548, ENST00000947549, ENST00000947550, ENST00000947551, ENST00000947552
RefSeq mRNA: 1 — MANE Select: NM_020179
NM_020179
CCDS: CCDS8292
Canonical transcript exons
ENST00000298966 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001098869 | 93499276 | 93499348 |
| ENSE00002194411 | 93478472 | 93479269 |
| ENSE00002196994 | 93543276 | 93543391 |
Expression profiles
Bgee: expression breadth ubiquitous, 262 present calls, max score 99.59.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.8418 / max 202.2657, expressed in 1542 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121825 | 2.8652 | 1147 |
| 121827 | 1.8615 | 943 |
| 121826 | 1.0574 | 682 |
| 121828 | 0.5985 | 291 |
| 121823 | 0.4125 | 122 |
| 121821 | 0.0466 | 20 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 99.59 | gold quality |
| secondary oocyte | CL:0000655 | 97.35 | gold quality |
| monocyte | CL:0000576 | 97.10 | gold quality |
| mononuclear cell | CL:0000842 | 97.03 | gold quality |
| leukocyte | CL:0000738 | 96.78 | gold quality |
| right lobe of liver | UBERON:0001114 | 96.17 | gold quality |
| jejunal mucosa | UBERON:0000399 | 95.23 | gold quality |
| oocyte | CL:0000023 | 94.94 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.93 | gold quality |
| granulocyte | CL:0000094 | 94.53 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.50 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.28 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.04 | gold quality |
| thyroid gland | UBERON:0002046 | 93.98 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.90 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 93.84 | gold quality |
| liver | UBERON:0002107 | 93.78 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.77 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 93.76 | gold quality |
| duodenum | UBERON:0002114 | 93.67 | gold quality |
| colonic mucosa | UBERON:0000317 | 93.46 | gold quality |
| ileal mucosa | UBERON:0000331 | 93.33 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 93.13 | gold quality |
| body of pancreas | UBERON:0001150 | 93.13 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.10 | gold quality |
| right uterine tube | UBERON:0001302 | 92.89 | gold quality |
| right testis | UBERON:0004534 | 92.76 | gold quality |
| adrenal gland | UBERON:0002369 | 92.71 | gold quality |
| left testis | UBERON:0004533 | 92.70 | gold quality |
| right atrium auricular region | UBERON:0006631 | 92.42 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-13 | yes | 23.34 |
| E-MTAB-6701 | yes | 17.79 |
| E-ANND-3 | yes | 13.00 |
| E-CURD-88 | yes | 8.08 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting SMCO4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-6716-5P | 99.56 | 68.62 | 1244 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-183-5P | 99.31 | 72.27 | 1164 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-5582-5P | 99.27 | 71.42 | 1879 |
| HSA-MIR-4667-3P | 99.26 | 65.45 | 1608 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-146A-3P | 99.13 | 68.99 | 1881 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Smco4 | ENSMUSG00000058173 |
| rattus_norvegicus | Smco4 | ENSRNOG00000011162 |
Protein
Protein identifiers
Single-pass membrane and coiled-coil domain-containing protein 4 — Q9NRQ5 (reviewed: Q9NRQ5)
Alternative names: Protein FN5
All UniProt accessions (3): E9PQ76, E9PSB8, Q9NRQ5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the SMCO4 family.
RefSeq proteins (1): NP_064564* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027960 | DUF4519 | Family |
Pfam: PF15012
UniProt features (5 total): chain 1, transmembrane region 1, region of interest 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NRQ5-F1 | 73.79 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 219 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, YANG_BREAST_CANCER_ESR1_LASER_DN, BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN, GTGCCTT_MIR506, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, VANTVEER_BREAST_CANCER_ESR1_DN, NUYTTEN_EZH2_TARGETS_DN, SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP, SMID_BREAST_CANCER_LUMINAL_B_DN, MULLIGHAN_MLL_SIGNATURE_1_UP, chr11q21, MYB_Q6, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, LI_INDUCED_T_TO_NATURAL_KILLER_UP, PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
266 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMCO4 | VSTM5 | A8MXK1 | 564 |
| SMCO4 | NEO1 | Q92859 | 519 |
| SMCO4 | ZNF195 | O14628 | 491 |
| SMCO4 | BKGD | Q9H0W9 | 490 |
| SMCO4 | PDZD11 | Q5EBL8 | 436 |
| SMCO4 | FN1 | P02751 | 435 |
| SMCO4 | DRAXIN | Q8NBI3 | 427 |
| SMCO4 | NTN1 | O95631 | 413 |
| SMCO4 | NUDT6 | P53370 | 403 |
| SMCO4 | HEPHL1 | Q6MZM0 | 400 |
| SMCO4 | NFASC | O94856 | 391 |
| SMCO4 | NTN5 | Q8WTR8 | 380 |
| SMCO4 | DCC | P43146 | 364 |
| SMCO4 | ZBBX | A8MT70 | 359 |
| SMCO4 | GALNT5 | Q7Z7M9 | 344 |
IntAct
184 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMCO4 | BNIP3L | psi-mi:“MI:0915”(physical association) | 0.780 |
| BNIP3L | SMCO4 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SMCO4 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP10-7 | SMCO4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | SMCO4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYNE4 | SMCO4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KASH5 | SMCO4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | SYNE4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SMCO4 | PTGES | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | SCN3B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | CD79A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | FFAR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | FAM210B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | SLC7A14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | M6PR | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (65): SMCO4 (Two-hybrid), KRT40 (Two-hybrid), CCDC155 (Two-hybrid), SYNE4 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-3 (Two-hybrid), BNIP3L (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid), SMCO4 (Two-hybrid)
ESM2 similar proteins: A0M8S0, A0M8T1, A0M8U1, A2VDK9, A3KN28, A4D7R9, A9JRA0, B5FXC9, P42553, P42554, Q00PJ0, Q07DV5, Q07DW9, Q07DX8, Q07DY8, Q07E08, Q07E45, Q09YH4, Q09YI5, Q09YJ7, Q09YK8, Q09YN2, Q0VCK9, Q108U3, Q1RLU8, Q2IBA8, Q2IBD0, Q2IBE0, Q2IBE8, Q2PG42, Q2QL86, Q2QLA6, Q2QLB7, Q2QLD7, Q2QLE8, Q2QLG2, Q32PD9, Q3ZAQ7, Q5RDV3, Q68FW3
Diamond homologs: A7RYM6, A7RYM7, B0WN94, B5FXC9, Q0IFA9, Q32PD9, Q6GP51, Q7PH91, Q8SY72, Q9I859, Q9JIS3, Q9NRQ5, Q09JL7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
401 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:93479267:CTC:C | acceptor_gain | 0.9900 |
| 11:93479268:TCC:T | acceptor_loss | 0.9900 |
| 11:93479270:C:CG | acceptor_loss | 0.9900 |
| 11:93479271:T:G | acceptor_loss | 0.9900 |
| 11:93499272:TTA:T | donor_loss | 0.9900 |
| 11:93479270:C:CC | acceptor_gain | 0.9800 |
| 11:93496323:T:TC | acceptor_gain | 0.9800 |
| 11:93479268:TC:T | acceptor_gain | 0.9700 |
| 11:93479269:CC:C | acceptor_gain | 0.9700 |
| 11:93499274:A:AC | donor_gain | 0.9700 |
| 11:93499275:C:CC | donor_gain | 0.9700 |
| 11:93479265:ACCTC:A | acceptor_gain | 0.9600 |
| 11:93479266:CCTCC:C | acceptor_gain | 0.9600 |
| 11:93479280:AACAA:A | acceptor_gain | 0.9600 |
| 11:93479282:CAA:C | acceptor_gain | 0.9600 |
| 11:93496323:T:C | acceptor_gain | 0.9600 |
| 11:93479272:G:C | acceptor_loss | 0.9400 |
| 11:93479281:ACAA:A | acceptor_gain | 0.9200 |
| 11:93479282:CAAC:C | acceptor_gain | 0.9200 |
| 11:93479267:CTCCT:C | acceptor_gain | 0.9100 |
| 11:93479272:G:GC | acceptor_gain | 0.8700 |
| 11:93499289:T:TA | donor_gain | 0.8500 |
| 11:93479266:CCTC:C | acceptor_gain | 0.8400 |
| 11:93479267:CTCC:C | acceptor_gain | 0.8400 |
| 11:93479268:TCCT:T | acceptor_gain | 0.8400 |
| 11:93496811:T:A | donor_gain | 0.8400 |
| 11:93497835:CTCT:C | acceptor_gain | 0.8200 |
| 11:93479269:C:G | acceptor_gain | 0.8100 |
| 11:93497834:ACTCT:A | acceptor_gain | 0.7900 |
| 11:93479293:G:GC | acceptor_gain | 0.7800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000036632 (11:93506786 T>C), RS1000103351 (11:93522291 A>G), RS1000145038 (11:93480173 T>C,G), RS1000192479 (11:93524377 C>T), RS1000195141 (11:93497343 G>A,C,T), RS1000210032 (11:93545226 A>G), RS1000281258 (11:93551298 T>C,G), RS1000324206 (11:93544875 T>C), RS1000361539 (11:93530364 G>C,T), RS1000382465 (11:93500005 A>G), RS1000419860 (11:93536539 T>A,C,G), RS1000448358 (11:93553488 A>G), RS1000541517 (11:93478896 C>A,T), RS1000602344 (11:93511426 AAG>A), RS1000606619 (11:93524059 A>C)
Disease associations
OMIM: gene MIM:609477 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005160_3 | Insulin levels in response to oral glucose tolerance test (30 minutes) | 9.000000e-06 |
| GCST010988_425 | Adult body size | 1.000000e-08 |
| GCST90013405_91 | Liver enzyme levels (alanine transaminase) | 2.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004307 | glucose tolerance test |
| EFO:0004467 | insulin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects cotreatment, decreases expression | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| potassium chromate(VI) | decreases expression, increases expression, affects cotreatment | 2 |
| Cisplatin | affects expression, increases expression | 2 |
| Tretinoin | decreases expression | 2 |
| Valproic Acid | decreases methylation, increases expression | 2 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 2 |
| Cyclosporine | decreases expression, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| periodate-oxidized adenosine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| chromium hexavalent ion | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| gardiquimod | decreases reaction, increases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | increases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | affects response to substance | 1 |
| Estradiol | decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.